Trials / Completed
CompletedNCT00149279
A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer
Randomized Controlled Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer (JCOG9501)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 520 (planned)
- Sponsor
- Japan Clinical Oncology Group · Academic / Other
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the survival benefit of para-aortic lymphadenectomy in potentially curative gastrectomy
Detailed description
Radical gastrectomy with regional lymphadenectomy is the only curative treatment option for gastric cancer. The extent of lymphadenectomy, however, is controversial. The two European randomized trials only reported an increase in operative morbidity and mortality, but failed to show survival benefit, in the D2 lymphadenectomy group. We conducted a randomized controlled trial to compare the Japanese standard D2 and D2 + para-aortic nodal dissection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Surgery: D2 dissection | |
| PROCEDURE | Surgery: D2+paraaortic dissection |
Timeline
- Start date
- 1995-07-01
- Completion
- 2006-04-01
- First posted
- 2005-09-08
- Last updated
- 2016-09-22
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00149279. Inclusion in this directory is not an endorsement.